Monday, August 24, 2026

BTC $79,137 ▲ 1.80%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.222−2.09%ETH$2,480+0.70%LINK$11.57+0.22%SOL$96.28+0.90%BTC$79,137+1.80%XRP$1.50−1.11%S&P 5007,660−0.19%Nasdaq26,074−0.41%Dow53,394+0.22%RUT2,999−0.64%TNX4.69%−0.97%TYX5.22%−1.12%FVX4.40%−0.47%IRX3.71%−0.08%VIX15.69+3.70%GOLD$4,713.20+0.70%SILVER$68.78−1.09%OIL$85.32−2.00%DXY98.99+0.20%NVDA$209.70−2.34%AAPL$313.18+1.24%TSLA$354.77−2.23%META$557.68+1.41%MSFT$488.91+1.17%AMZN$263.00+1.69%GOOGL$351.06+1.81%Fear & Greed73 — GreedADA$0.222−2.09%ETH$2,480+0.70%LINK$11.57+0.22%SOL$96.28+0.90%BTC$79,137+1.80%XRP$1.50−1.11%S&P 5007,660−0.19%Nasdaq26,074−0.41%Dow53,394+0.22%RUT2,999−0.64%TNX4.69%−0.97%TYX5.22%−1.12%FVX4.40%−0.47%IRX3.71%−0.08%VIX15.69+3.70%GOLD$4,713.20+0.70%SILVER$68.78−1.09%OIL$85.32−2.00%DXY98.99+0.20%NVDA$209.70−2.34%AAPL$313.18+1.24%TSLA$354.77−2.23%META$557.68+1.41%MSFT$488.91+1.17%AMZN$263.00+1.69%GOOGL$351.06+1.81%Fear & Greed73 — Greed

Tag

MRNA

2 articles

U.S. EquitiesYesterday

Moderna Surges 177% on Melanoma Vaccine Win; Wall Street Raises Targets

Moderna stock soared on positive Phase 3 results for its personalized melanoma vaccine with Merck, prompting Morgan Stanley to raise its price target to $89 from $39.

U.S. Equities2d ago

Moderna Stock Drops 25% on Cancer Vaccine Success—Wall Street's Skepticism Shows Risk

Investors sold despite positive melanoma vaccine trial results, pointing to lingering doubts about Moderna's ability to execute beyond COVID and generate sustainable returns.